mntr ~~>> not me d, yes it is nice to see the b/a tightin..
Mentor Capital targets to efficiently raise approximately $125 Million from warrant proceeds for operating cancer companies often like those in the Cancer Immunotherapy Index and to invest in those or related leading-edge firms via stock purchase or acquisition.